Renfu Medicine: Change of controlling shareholder and actual controller completed.

Renfu Pharmaceuticals Announcement: The company will hold its 2025 third extraordinary general meeting of shareholders on July 30, 2025 to review and approve the election of the new board of directors. As of now, the largest shareholder of the company, China Merchants Life Science and Technology Co., Ltd., has completed the restructuring of the board of directors and has taken control of the company. The controlling shareholder of the company has been changed to China Merchants Life Science and the actual controller has been changed to China Merchants Group Co., Ltd. On June 26, 2025, Contemporary Technology completed the transfer of 387 million shares of Renfu Pharmaceuticals through judicial transfer. Through this share transfer, China Merchants Life Science directly holds, indirectly holds through its controlled limited partnership, and accepts voting rights through trust plans to collectively control 387 million ordinary shares of the company, accounting for 23.70% of the total share capital of the company.